The proposed bill, known as the Abortion Pill Provider Liability Education (APPLE) Act, seeks to establish new regulations regarding the prescription of abortion-inducing drugs, specifically RU-486 (mifepristone). Under the new section 2317.57 of the Revised Code, health care providers must meet specific conditions before prescribing such drugs, including providing written instructions and information about potential complications, as well as obtaining written certification from the pregnant woman that she has received and reviewed this information. The bill also mandates that health care providers retain this certification in the patient's medical file for a minimum of seven years.

Additionally, the bill outlines civil liabilities for health care providers who fail to comply with these requirements, allowing affected individuals, such as the woman prescribed the drug or her family members, to pursue legal action. If successful, claimants may receive damages for injuries and statutory damages equal to three times the cost of the drug. The bill also empowers the attorney general or local prosecutors to investigate violations and impose civil penalties on non-compliant providers, with penalties reaching up to $5,000 per day for each violation. The Department of Health is tasked with creating a form for health care providers to use in compliance with these new regulations.